Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Chem Biol ; 8(11): 2442-51, 2013 Nov 15.
Article in English | MEDLINE | ID: mdl-23957438

ABSTRACT

Modern medicine is founded on the discovery of penicillin and subsequent small molecules that inhibit bacterial peptidoglycan (PG) and cell wall synthesis. However, the discovery of new chemically and mechanistically distinct classes of PG inhibitors has become exceedingly rare, prompting speculation that intracellular enzymes involved in PG precursor synthesis are not 'druggable' targets. Here, we describe a ß-lactam potentiation screen to identify small molecules that augment the activity of ß-lactams against methicillin-resistant Staphylococcus aureus (MRSA) and mechanistically characterize a compound resulting from this screen, which we have named murgocil. We provide extensive genetic, biochemical, and structural modeling data demonstrating both in vitro and in whole cells that murgocil specifically inhibits the intracellular membrane-associated glycosyltransferase, MurG, which synthesizes the lipid II PG substrate that penicillin binding proteins (PBPs) polymerize and cross-link into the cell wall. Further, we demonstrate that the chemical synergy and cidality achieved between murgocil and the ß-lactam imipenem is mediated through MurG dependent localization of PBP2 to the division septum. Collectively, these data validate our approach to rationally identify new target-specific bioactive ß-lactam potentiation agents and demonstrate that murgocil now serves as a highly selective and potent chemical probe to assist our understanding of PG biosynthesis and cell wall biogenesis across Staphylococcal species.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Outer Membrane Proteins/antagonists & inhibitors , N-Acetylglucosaminyltransferases/antagonists & inhibitors , Peptidoglycan Glycosyltransferase/metabolism , Pyrazoles/pharmacology , Staphylococcus aureus/drug effects , Sterols/pharmacology , Computer Simulation , Drug Resistance, Bacterial , Enzyme Inhibitors/pharmacology , Humans , Microscopy, Fluorescence , Models, Molecular , Pyrazoles/chemistry , Staphylococcus aureus/enzymology , Sterols/chemistry
2.
Appl Environ Microbiol ; 74(4): 1136-44, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18156322

ABSTRACT

Lactococcus lactis subsp. lactis biovar diacetylactis CRL264 is a natural strain isolated from cheese (F. Sesma, D. Gardiol, A. P. de Ruiz Holgado, and D. de Mendoza, Appl. Environ. Microbiol. 56:2099-2103, 1990). The effect of citrate on the growth parameters at a very acidic pH value was studied with this strain and with derivatives whose citrate uptake capacity was genetically manipulated. The culture pH was maintained at 4.5 to prevent alkalinization of the medium, a well-known effect of citrate metabolism. In the presence of citrate, the maximum specific growth rate and the specific glucose consumption rate were stimulated. Moreover, a more efficient energy metabolism was revealed by analysis of the biomass yields relative to glucose consumption or ATP production. Thus, it was shown that the beneficial effect of citrate on growth under acid stress conditions is not primarily due to the concomitant alkalinization of the medium but stems from less expenditure of ATP, derived from glucose catabolism, to achieve pH homeostasis. After citrate depletion, a deleterious effect on the final biomass was apparent due to organic acid accumulation, particularly acetic acid. On the other hand, citrate metabolism endowed cells with extra ability to counteract lactic and acetic acid toxicity. In vivo 13C nuclear magnetic resonance provided strong evidence for the operation of a citrate/lactate exchanger. Interestingly, the greater capacity for citrate transport correlated positively with the final biomass and growth rates of the citrate-utilizing strains. We propose that increasing the citrate transport capacity of CRL264 could be a useful strategy to improve further the ability of this strain to cope with strongly acidic conditions.


Subject(s)
Citric Acid/metabolism , Lactococcus lactis/growth & development , Adenosine Triphosphate/metabolism , Carbon Radioisotopes , Chromatography, High Pressure Liquid , Fermentation , Glucose/metabolism , Hydrogen-Ion Concentration , Lactococcus lactis/metabolism , Nuclear Magnetic Resonance, Biomolecular
3.
Yeast ; 21(8): 635-48, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15197729

ABSTRACT

S. cerevisiae responds to the presence of amino acids in the environment through the membrane-bound complex SPS, by altering transcription of several genes. Global transcription analysis shows that 46 genes are induced by L-citrulline. Under the given conditions there appears to be only one pathway for induction with L-citrulline, and this pathway is completely dependent on the SPS component, Ssy1p, and either of the transcription factors, Stp1p and Stp2p. Besides the effects on amino acid permease genes, an ssy1 and an stp1 stp2 mutant exhibit a number of other transcriptional phenotypes, such as increased expression of genes subject to nitrogen catabolite repression and genes involved in stress response. A group of genes involved in the upper part of the glycolysis, including those encoding hexose transporters Hxt4p, Hxt5p, Hxt6p, Hxt7p, hexokinase Hxk1p, glyceraldehyde 3-phosphate dehydrogenase Tdh1p and glucokinase (Glk1p), shows increased transcription levels in either or both of the mutants. Also, most of the structural genes involved in trehalose and glycogen synthesis and a few genes in the glyoxylate cycle and the pentose phosphate pathway are derepressed in the ssy1 and stp1 stp2 strains.


Subject(s)
Citrulline/biosynthesis , DNA-Binding Proteins/physiology , Nuclear Proteins/physiology , RNA-Binding Proteins/physiology , Saccharomyces cerevisiae Proteins/physiology , Saccharomyces cerevisiae/genetics , Transcription Factors/physiology , Transcription, Genetic/physiology , Citrulline/physiology , DNA-Binding Proteins/genetics , Gene Expression Profiling , Intracellular Signaling Peptides and Proteins , Membrane Proteins/genetics , Membrane Proteins/physiology , Nuclear Proteins/genetics , RNA-Binding Proteins/genetics , Saccharomyces cerevisiae Proteins/genetics , Transcription Factors/genetics
4.
Eukaryot Cell ; 2(3): 599-608, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12796305

ABSTRACT

A detailed characterization of the central metabolic network of Saccharomyces cerevisiae CEN.PK 113-7D was carried out during cometabolism of different mixtures of glucose and acetate, using aerobic C-limited chemostats in which one of these two substrates was labeled with (13)C. To confirm the role of malic enzyme, an isogenic strain with the corresponding gene deleted was grown under the same conditions. The labeling patterns of proteinogenic amino acids were analyzed and used to estimate metabolic fluxes and/or make inferences about the in vivo activities of enzymes of the central carbon metabolism and amino acid biosynthesis. Malic enzyme flux increased linearly with increasing acetate fraction. During growth on a very-high-acetate fraction, the activity of malic enzyme satisfied the biosynthetic needs of pyruvate in the mitochondria, while in the cytosol pyruvate was supplied via pyruvate kinase. In several cases enzyme activities were unexpectedly detected, e.g., the glyoxylate shunt for a very-low-acetate fraction, phosphoenolpyruvate carboxykinase for an acetate fraction of 0.46 C-mol of acetate/C-mol of substrate, and glucose catabolism to CO(2) via the tricarboxylic acid cycle for a very-high-acetate fraction. Cytoplasmic alanine aminotransferase activity was detected, and evidence was found that alpha-isopropylmalate synthase has two active forms in vivo, one mitochondrial and the other a short cytoplasmic form.


Subject(s)
Acetates/metabolism , Carbon/metabolism , Glucose/metabolism , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/metabolism , Amino Acids/metabolism , Biomass , Citric Acid Cycle , Cytosol/metabolism , Gene Deletion , Genes, Fungal , Malate Dehydrogenase/genetics , Malate Dehydrogenase/metabolism , Mitochondria/metabolism , Mutation , Pyruvate Kinase/metabolism , Pyruvic Acid/metabolism , Saccharomyces cerevisiae/genetics , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL